Free Trial

Heron Therapeutics (HRTX) SEC Filings & 10K Form

Heron Therapeutics logo
$1.19 -0.05 (-4.03%)
(As of 11/15/2024 ET)

Recent Heron Therapeutics SEC Filings

DateFilerForm TypeView
11/12/2024
8:32 AM
Adage Capital Management, L.P. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G
11/06/2024
1:08 PM
Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
11:41 AM
Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/04/2024
4:09 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G
10/21/2024
2:49 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
2:53 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:35 PM
Heron Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/22/2024
8:44 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
8:54 AM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
8:32 AM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:44 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
3:43 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
1:21 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:34 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
10:08 AM
Heron Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
05/29/2024
7:05 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:05 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:05 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
1:33 PM
Heron Therapeutics (Filer)
Form DEF 14A
04/29/2024
1:36 PM
Heron Therapeutics (Filer)
Form ARS
04/19/2024
4:48 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:02 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:21 PM
Heron Therapeutics (Filer)
Form PRE 14A
04/19/2024
3:34 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:32 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:46 AM
Deep Track Capital, LP (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
02/06/2024
10:43 AM
FRANKLIN RESOURCES INC (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
01/24/2024
7:01 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
7:58 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:00 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:01 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:01 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:02 PM
Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:03 PM
Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:04 PM
Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:04 PM
Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:05 PM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
4:19 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:07 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:30 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
2024's Must-Watch Stocks! (Ad)

Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

12/21/2023
4:25 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
1:45 PM
Heron Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
12/06/2023
3:47 PM
BlackRock Inc. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
11/21/2023
11:19 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
9:07 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
11:36 AM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
11:37 AM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HRTX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners